How do the EMA and FDA decide which anticancer drugs make it to the market?: a comparative qualitative study on decision makers' views
Gespeichert in:
| Weitere Verfasser: | , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
2014
|
| In: |
Annals of oncology
Year: 2014, Jahrgang: 25, Heft: 1, Pages: 265-269 |
| ISSN: | 1569-8041 |
| DOI: | 10.1093/annonc/mdt512 |
| Online-Zugang: | Verlag, kostenfrei, Volltext: http://dx.doi.org/10.1093/annonc/mdt512
|
| Verfasserangaben: | G. Tafuri, P. Stolk, F. Trotta, M. Putzeist, H. G. Leufkens, R. O. Laing, and M. De Allegri |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1480577774 | ||
| 003 | DE-627 | ||
| 005 | 20230426123039.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 140808s2014 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1093/annonc/mdt512 |2 doi | |
| 024 | 7 | |a 174360224 |2 swets | |
| 035 | |a (DE-627)1480577774 | ||
| 035 | |a (DE-576)410577774 | ||
| 035 | |a (DE-599)BSZ410577774 | ||
| 035 | |a (OCoLC)1340643777 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 245 | 0 | 0 | |a How do the EMA and FDA decide which anticancer drugs make it to the market? |b a comparative qualitative study on decision makers' views |c G. Tafuri, P. Stolk, F. Trotta, M. Putzeist, H. G. Leufkens, R. O. Laing, and M. De Allegri |
| 264 | 1 | |c 2014 | |
| 300 | |a 5 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 08.08.2014 | ||
| 700 | 1 | |a Tafuri, Giovanni |4 oth | |
| 700 | 1 | |a De Allegri, Manuela |d 1975- |0 (DE-588)131974904 |0 (DE-627)516328913 |0 (DE-576)298870975 |4 oth | |
| 773 | 0 | 8 | |i In |t Annals of oncology |d Amsterdam [u.a.] : Elsevier, 1990 |g 25(2014), 1, Seite 265-269 |h Online-Ressource |w (DE-627)320428796 |w (DE-600)2003498-2 |w (DE-576)098134345 |x 1569-8041 |7 nnas |a How do the EMA and FDA decide which anticancer drugs make it to the market? a comparative qualitative study on decision makers' views |
| 773 | 1 | 8 | |g volume:25 |g year:2014 |g number:1 |g pages:265-269 |g extent:5 |a How do the EMA and FDA decide which anticancer drugs make it to the market? a comparative qualitative study on decision makers' views |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1093/annonc/mdt512 |x Verlag |x Resolving-System |z kostenfrei |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20140808 | ||
| 993 | |a Article | ||
| 994 | |a 2014 | ||
| 998 | |g 131974904 |a De Allegri, Manuela |m 131974904:De Allegri, Manuela |d 910000 |d 912800 |e 910000PD131974904 |e 912800PD131974904 |k 0/910000/ |k 1/910000/912800/ |p 7 |y j | ||
| 999 | |a KXP-PPN1480577774 |e 2810928819 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"physDesc":[{"extent":"5 S."}],"origin":[{"dateIssuedKey":"2014","dateIssuedDisp":"2014"}],"name":{"displayForm":["G. Tafuri, P. Stolk, F. Trotta, M. Putzeist, H. G. Leufkens, R. O. Laing, and M. De Allegri"]},"relHost":[{"id":{"issn":["1569-8041"],"zdb":["2003498-2"],"eki":["320428796"]},"disp":"How do the EMA and FDA decide which anticancer drugs make it to the market? a comparative qualitative study on decision makers' viewsAnnals of oncology","language":["eng"],"type":{"bibl":"periodical","media":"Online-Ressource"},"title":[{"title":"Annals of oncology","title_sort":"Annals of oncology","subtitle":"official journal of the European Society for Medical Oncology"}],"physDesc":[{"extent":"Online-Ressource"}],"pubHistory":["1.1990 -"],"part":{"year":"2014","text":"25(2014), 1, Seite 265-269","issue":"1","extent":"5","pages":"265-269","volume":"25"},"note":["Gesehen am 12.11.20","Ungezählte Beil.: Supplement"],"corporate":[{"role":"isb","display":"European Society for Medical Oncology"}],"recId":"320428796","origin":[{"publisherPlace":"Amsterdam [u.a.] ; Dordrecht [u.a.] ; Oxford","dateIssuedKey":"1990","dateIssuedDisp":"1990-","publisher":"Elsevier ; Kluwer ; Oxford Univ. Press"}]}],"recId":"1480577774","title":[{"title":"How do the EMA and FDA decide which anticancer drugs make it to the market?","title_sort":"How do the EMA and FDA decide which anticancer drugs make it to the market?","subtitle":"a comparative qualitative study on decision makers' views"}],"language":["eng"],"person":[{"family":"Tafuri","given":"Giovanni","display":"Tafuri, Giovanni","role":"oth"},{"given":"Manuela","family":"De Allegri","role":"oth","display":"De Allegri, Manuela"}],"type":{"media":"Online-Ressource","bibl":"article-journal"},"id":{"eki":["1480577774"],"doi":["10.1093/annonc/mdt512"]},"note":["Gesehen am 08.08.2014"]} | ||
| SRT | |a HOWDOTHEEM2014 | ||